Wang et al.
1195
tracted with ethyl ether (3 × 10 mL). After drying, the com-
bined ether layers were concentrated under reduced pressure
and the resulting residue was charged on a silica gel column
and eluted with a mixture of ethyl acetate/n-hexane (1:8) to
obtain product 3. All products were fully characterized by
C H N: C 87.99, H 6.61, and N 5.40; found: C 88.07, H
6.52, and N 5.48.
1
8
17
6-Chloro-2,4-diphenylquinoline (3g)
–
1
mp 130–132 °C (lit. (11) 130–131 °C). IR ν (cm ): 3050,
1
1
IR, H NMR, MS, and elemental analysis. The aqueous so-
1610, and 1589. H NMR (400 MHz, CDCl3) δ: 8.11–8.15
lution of ionic liquid and catalyst was concentrated at re-
duced pressure to recover the ionic liquid and catalyst for
subsequent reuse.
(m, 3H), 7.82 (d, 1H, J = 2.2 Hz), 7.76 (s, 1H), 7.59–7.60
+
(m, 2H), and 7.45–7.50 (m, 7H). MS m/z (%): 317 (M + 2,
+
33), 315 (M , 100), and 280 (32). Anal. calcd. for
C H ClN: C 79.87, H 4.47, and N 4.44; found: C 79.95, H
2
1
14
2
,4-Diphenylquinoline (3a)
4.43, and N 4.35.
mp 110–111 °C (lit. (9) 112–113 °C). 1H NMR
6
-Chloro-2-(4-bromophenyl)-4-phenylquinoline (3h)
(
(
400 MHz, CDCl ) δ: 8.26 (d, 1H, J = 8.4 Hz), 8.19–8.22
m, 2H), 7.91 (dd, 1H, J = 8.4 Hz, J = 1.2 Hz), 7.83 (s,
3
–
1
mp 174–176 °C (lit. (11) 174–175 °C). IR ν (cm ): 3061,
1
2
1
1
600, and 1590. H NMR (400 MHz, CDCl ) δ: 8.14 (d, 1H,
1
H), 7.72–7.76 (m, 1H), and 7.47–7.59 (m, 9H). MS m/z
3
+
+
J = 8.8 Hz), 8.07 (d, 2H, J = 8.8 Hz), 7.85 (d, 1H, J =
(
%): 281 (M , 70), 280 (M – 1, 100), 202 (9), and 139 (8).
2
5
.2 Hz), 7.79 (s, 1H), 7.64–7.68 (m, 3H), and 7.54–7.58 (m,
+
+
H). MS m/z (%): 397 (M + 4, 26), 395 (M + 2, 100), 393
2
-(4-Bromophenyl)-4-phenylquinoline (3b)
mp 128–129 °C. IR ν (cm ) : 3050, 1610, and 1590. H
+
–
1
1
(M , 79), and 358 (18). Anal. calcd. for C H BrClN: C
21 13
6
3
3.90, H 3.32, and N 3.55; found: C 63.85, H 3.21, and N
.53.
NMR (400 MHz, CDCl ) δ: 8.23 (d, 1H, J = 8.0 Hz), 8.08–
3
8
7
.11 (m, 2H), 7.90 (d, 1H, J = 8.0 Hz), 7.72–7.78 (m, 2H),
.64–7.67 (m, 2H), and 7.47–7.59 (m, 6H). MS m/z (%): 361
+
+
6-Chloro-2-(4-chlorophenyl)-4-phenylquinoline (3i)
(
M +2, 89), 359 (M , 100), 278 (40), 202 (17), and 139
25). Anal. calcd. for C H BrN: C 70.01, H 3.92, and N
–
1
mp 164–166 °C (lit.(11) 159–160 °C). IR ν (cm ): 3058,
(
2
1
14
1
1
605, and 1587. H NMR (400 MHz, CDCl ) δ: 8.26 (d, 1H,
3
3
.89; found: C 69.85, H 3.88, and N 3.73.
J = 8.4 Hz), 8.15 (d, 2H, J = 8 Hz), 7.87 (d, 1H, J = 2.2 Hz),
7
.80 (s, 1H), 7.68–7.71 (m, 1H), and 7.50–7.59 (m, 7H).
2
-(4-Nitrophenyl)-4-phenylquinoline (3c)
+
+
+
–
1
MS m/z (%): 353 (M + 4, 12), 351 (M + 2, 65), 349 (M ,
100), and 314 (34). Anal. calcd. for C21H13Cl2N: C 72.02, H
3
mp 162–163 °C (lit. (9) 156–161 °C). IR ν (cm ): 3061,
1
1
620, and 1595. H NMR (400 MHz, CDCl ) δ: 8.37–8.42
3
.74, and N 4.00; found: C 72.07, H 3.71, and N 4.03.
(
m, 4H), 8.31 (d, 1H, J = 8.0 Hz), 7.96 (d, 1H, J = 8.0 Hz),
7
6
.87 (s, 1H), 7.80 (t, 1H, J = 8.0 Hz), and 7.54 –7.59 (m,
H). MS m/z (%): 326 (M , 100) and 202 (23). Anal. calcd.
6
-Chloro-2-(4-methylphenyl)-4-phenylquinoline (3j)
+
1
–1
mp 132–134 °C (lit. 1 132–133). IR ν (cm ): 3048, 1600,
for C H N O : C 77.29, H 4.32, and N 8.58; found: C
1
2
1
14
2
2
and 1580. H NMR (400 MHz, CDCl ) δ: 8.20 (d, 1H, J =
3
7
2
2
7.15, H 4.48, and N 8.63.
8
7
2
3
.4 Hz), 8.09 (d, 2H, J = 8.0 Hz), 7.85 (d, 1H, J = 3.5 Hz),
.82 (s, 1H), 7.67–7.64 (m, 1H), 7.57–7.52 (m, 5H), 7.33 (d,
-Methyl-4-phenylquinoline (3d)
+
H, J = 8.0 Hz), and 2.43 (s, 3H). MS m/z (%): 331 (M + 2,
–
1
mp 93–95 °C (lit. (10) 92–94 °C). IR ν (cm ): 3057,
+
4), 329 (M , 100), and 294 (23). Anal. calcd. for
.
1
971, 1617, and 1485 H NMR (400 MHz, CDCl ) δ: 8.09
3
C H ClN: C 80.11, H 4.89, and N 4.25; found: C 80.25, H
2
2
16
(
d, 1H, J = 8.4 Hz), 7.85 (dd, 1H, J = 8.4 Hz, J = 0.8 Hz),
1 2
4
.78, and N 4.33.
7
7
2
.66–7.70 (m, 1H), 7.45–7.55 (m, 5H), 7.40–7.45 (m, 1H),
+
.22 (s, 1H), and 2.77 (s, 3H). MS m/z (%): 219 (M , 100),
6
-Chloro-2-(4-nitrophenyl)-4-phenylquinoline (3k)
04 (14), and 176 (10). Anal. calcd. for C H N: C 87.64,
–1
1
1
6
13
mp 218–220 °C. IR ν (cm ): 3038, 1610, and 1525. H
H 5.98, and N 6.39; found: C 87.48, H 6.12, and N 6.46.
NMR (400 MHz, CDCl ) δ: 8.34–8.38 (m, 4H), 8.20 (d, 1H,
J = 8.0 Hz), 7.90 (d, 1H, J = 2.4 Hz), 7.88 (s, 1H), 7.23 (dd,
3
2
,3-Dihydro-9-phenyl-1H-cyclopenta[b]-quinoline (3e)
1
H, J = 9.2 Hz, J = 2.4 Hz), and 7.54–7.60 (m, 5H).
1 2
–
1
mp 104–105.5 °C (lit. (4) 134– 135 °C). IR ν (cm ) :
+
+
MS m/z (%): 362 (M + 2, 34), 360 (M , 100), 314 (40), 278
1
3
8
7
8
1
8
5
011, 2968, 1610, and 1455. H NMR (400 MHz, CDCl ) δ:
3
(32), and 139 (20). Anal. calcd. for C H ClN O : C 69.91,
H 3.63, and N 7.76; found: C 69.94, H 3.68, and N 7.59.
2
1
13
2
2
.06–8.08 (m, 1H), 7.60–7.64 (m, 2H), 7.45–7.55 (m, 3H),
.35–7.40 (m, 3H), 3.24 (t, 2H, J = 8.0 Hz), 2.91 (t, 2H, J =
+
.0 Hz), and 2.13–2.21 (m, 2H). MS m/z (%): 245 (M ,
6
-Chloro-2-methyl-4-phenylquinoline (3l)
–
1
00), 217 (9), and 168 (14). Anal. calcd. for C H N: C
1
8
15
mp 88–90 °C. IR ν (cm ): 3050, 2978, 1610, and 1496.
1
8.13, H 6.16, and N 5.71; found: C 88.18, H 6.02, and N
.86.
H NMR (400 MHz, CDCl ) δ: 8.02 (d, 1H, J = 9.2 Hz),
3
7
.82 (d, 1H, J = 2.4 Hz), 7.62 (dd, 1H, J = 9.2 Hz, J =
1 2
2
.4 Hz), 7.46–7.57 (m, 5H), 7.24 (s, 1H), and 2.77 (s, 3H).
+
+
1
,2,3,4-Tetrahydro-9-phenylacridine (3f)
MS m/z (%): 255 (M + 2, 32), 253 (M , 100), 218 (40), and
176 (11). Anal. calcd. for C H ClN: C 75.74, H 4.77, and
N 5.52; found: C 75.88, H 4.62, and N 5.63.
–
1
mp 131–133 °C (lit. (4) 142–143 °C). IR ν (cm ) : 3020,
1
6
12
1
2
978, 1600, and 1495. H NMR (400 MHz, CDCl ) δ: 8.06
3
(
d, 1H, J = 8.0 Hz), 7.59–7.64 (m, 1H), 7.43–7.55 (m, 3H),
7
8
.28–7.34 (m, 4H), 3.23 (t, 2H, J = 8.0 Hz), 2.59 (t, 2H, J =
6-Chloro-2,3-dimethyl-4-phenylquinoline (3m)
–
1
.0 Hz), 1.94–2.00 (m, 2H), and 1.76–1.83 (m, 2H). MS m/z
mp 121–124 °C. IR ν (cm ): 3035, 2959, 1610, and 1459.
+
1
(
%): 259 (M , 100), 230 (12), and 182 (6). Anal. calcd. for
H NMR (400 MHz, CDCl ) δ: 7.95 (d, 1H, J = 9.2 Hz),
3
©
2004 NRC Canada